Skip to main content
Clinical Trials/JPRN-C000000026
JPRN-C000000026
Completed
Phase 3

Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401) - Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401)

Japan Clinical Oncology Group(JCOG)0 sites210 target enrollmentJuly 22, 2005
Conditionsprostate cancer

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
prostate cancer
Sponsor
Japan Clinical Oncology Group(JCOG)
Enrollment
210
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 22, 2005
End Date
May 1, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Japan Clinical Oncology Group(JCOG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ; 2\) mental disease or mental symptoms which would affect participant's decision to participate; 3\) continuous medication of steroids (exclude external use of steroids for skin) ; 4\) ischemic heart disease or arrhythmia which needs medical treatment; 5\) poorly controlled hypertension; 6\) poorly controlleddiabetes mellitus; 7\) history of cerebral infarction or myocardial infarction within 6 months; 8\) liver cirrhosis 9\) interstitial pneumonia which requires ventilation assistance, oxygen inhalation, steroids, or diuretic medicine

Outcomes

Primary Outcomes

Not specified

Similar Trials